Biblio
Export 180 results:
Author Keyword Title Type [ Year
Filters: First Letter Of Title is I [Clear All Filters]
“Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1907-1916, 2022.
, “Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions.”, J Alzheimers Dis, vol. 89, no. 2, pp. 563-570, 2022.
, “Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.”, J Alzheimers Dis, vol. 90, no. 4, pp. 1739-1747, 2022.
, “Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding.”, J Alzheimers Dis, 2022.
, “Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.”, J Alzheimers Dis, vol. 89, no. 2, pp. 681-693, 2022.
, “Increased Functional Connectivity of the Precuneus in Individuals with a Family History of Alzheimer's Disease.”, J Alzheimers Dis, 2022.
, “Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults.”, J Alzheimers Dis, vol. 88, no. 1, pp. 311-32, 2022.
, “An Investigation into the Effects of Outer Membrane Vesicles and Lipopolysaccharide of Porphyromonas gingivalis on Blood-Brain Barrier Integrity, Permeability, and Disruption of Scaffolding Proteins in a Human in vitro Model.”, J Alzheimers Dis, vol. 86, no. 1, pp. 343-364, 2022.
, “Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
, “Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1667-1676, 2021.
, “The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports.”, J Alzheimers Dis, vol. 80, no. 2, pp. 865-875, 2021.
, “Impact of Social Isolation on People with Dementia and Their Family Caregivers.”, J Alzheimers Dis, vol. 81, no. 2, pp. 607-617, 2021.
, “Impacts of Iron Metabolism Dysregulation on Alzheimer's Disease.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1439-1450, 2021.
, “Implementing Delirium Prevention in the Era of COVID-19.”, J Alzheimers Dis, vol. 79, no. 1, pp. 31-36, 2021.
, “Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale.”, J Alzheimers Dis, vol. 79, no. 4, pp. 1735-1745, 2021.
, “In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 82, no. 1, pp. 317-325, 2021.
, “In vivo Characterization of Biochemical Variants of Amyloid-β in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease Neuropathological Change.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1003-1012, 2021.
, “Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1679-1690, 2021.
, “Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study.”, J Alzheimers Dis, vol. 81, no. 1, pp. 329-338, 2021.
, “Inhibitory Fcγ Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 3, pp. 965-968, 2021.
, “Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer's Disease and Cognitive Function.”, J Alzheimers Dis, vol. 84, no. 2, pp. 787-796, 2021.
, “An Introduction to Ultrasensitive Assays for Plasma Tau Detection.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1353-1362, 2021.
, “Iron Responsive Element-Mediated Responses to Iron Dyshomeostasis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 4, pp. 1597-1630, 2021.
, “An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1639-1653, 2020.
, “The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 573-585, 2020.
,